Health Care Equipment & Services

Enovis insider buying signals confidence in its anti‑IL‑23 drug & diagnostic assays, despite negative earnings—potential game‑changer for psoriasis and rheumatoid arthritis care.

Beta Bionics insider sale shows disciplined, plan‑based trading amid phase‑III trials—insight into executive confidence and future upside potential.

Insider sales at Elevance Health reveal how a CMS suspension and rising regulatory pressures are reshaping Medicare Advantage, offering investors insight into volatility, strategy, and future upside.

Insider selling by Intuitive Surgical’s SVP shows routine, Rule 10b5‑1‑planned trades, while European distribution gains and strong clinical data keep investors confident in steady growth.

Teleflex CFO’s 400% jump in shares signals strong insider confidence in its growth strategy, hinting at a possible upside for investors.

Medtronic CFO Thierry Piéton’s recent share sale signals routine portfolio rebalancing amid market dips, but investors should watch insider trends and the GE HealthCare partnership for future moves.

ClearPoint Neuro insider moves reveal long‑term confidence amid a 36 % stock slide—insights on RSU activity, liquidity tactics, and future strategy.

Insider buys reveal VSee Health’s confidence in a turnaround and GoMyRx partnership – could the low‑priced stock rebound?

ClearPoint Neuro insider buys signal confidence: COO’s March 2026 trade shows strategic buying as stock dips, hinting at a potential rebound.

Wampler Kira Scherer’s insider buy of 2,000 Doximity shares signals confidence in the health‑tech platform’s security, growth prospects, and regulatory readiness—insights for clinicians and investors alike.